BioUtah News
-
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
-
Tellus Wellness Taps Nomi Health as Its Partner to Pay Providers
Nomi’s payment infrastructure shortens Tellus’ payment cycle from as much as 30-60 days to just one day.
-
Edwards Lifesciences to Sell Critical Care to BD
Agreement strengthens Edwards’ strategy to advance structural heart innovation.
-
Turner Imaging Systems Celebrates Landmark 300th SMART-C Sale to Surgical Center of Greensboro
Turner Imaging announced a significant milestone as they celebrate the sale of their 300th SMART-C system to the…
-
Governor Cox Tours Teva, Stryker and ARUP Laboratories
Gov. Cox this week toured Teva Pharmaceuticals, Stryker, and ARUP Laboratories to see firsthand the life-changing technology and…
-
Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB) today…
-
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
Published open-access today in Nature Genetics, “High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR–Cas9 editing” identifies novel…
-
CLENE PROVIDES UPDATE ON ITS NIH-FUNDED EXPANDED ACCESS PROGRAM FOR CNM-AU8® IN ALS (ACT-EAP)
First patient, first visit is planned for early June 2024
-
SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES
SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES
-
James LeVoy Sorenson Center for Medical Innovation groundbreaking
A new campus building will place the University of Utah at the forefront of medical device innovation.
-
Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance
Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance
-
Videra Health Secures 5.6M in Funding to Advance Mental Health AI Solutions Led by Peterson Ventures
New investment drives development of advanced AI tools for mental health care screening and monitoring
-
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone
The UCLA research team created a low cost and customizable lipid nanoparticle using “click chemistry” for precise targeting…
-
Salt Lake City Named an Up-and-Coming U.S. Biotech Hotspot
These three U.S. cities are putting themselves on the biotech map as unsung hubs of the industry.
-
Merit Medical Launches basixSKY™ Inflation Device
Versatile analog device offers fast inflation and ease of use, streamlining patient care
-
PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foot Ulcers
PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foot Ulcers
-
Sorriso Pharmaceuticals Announces First Patients Dosed in Phase 1b Clinical Trial for Patients with Ulcerative Colitis
Study to Evaluate SOR102, a Novel Oral Dual-Acting Antibody Targeting TNF⍺ and IL-23 (p19) for Inflammatory Bowel Disease
-
EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections
Major Milestone for EVŌQ Nano’s Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung…
-
Merit Medical Shareholders Elect Silvia M. Perez as New Director
Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership to Merit’s Board…
-
EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections
Major Milestone for EVŌQ Nano’s Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung…
-
Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer’s Disease at Discovery Europe 2024
Dr. Bearss will be the Chair of the “Drug Discovery for Neurodegenerative Diseases” session, on May 23.
-
Merit Medical Executive Leadership Team Update
Joe Wright Appointed President, Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program.
-
Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe
New products broaden Merit’s leadership in embolotherapy.
-
Owlet Announces UK Medical Certification of Dream Sock®
Parents in the United Kingdom will soon have access to Owlet’s Dream Sock with UKCA certification.
-
PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study to Improve Symptoms Beyond the Current Standard of Care
Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underway.
-
Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry
BioHive-2, an NVIDIA DGX SuperPOD with NVIDIA DGX H100 systems, ranked #35 in the TOP500 list of the…
-
BioHive Live Recap
BioHive Live, BioHive’s inaugural industry-wide event with over 350 registrants took center stage at the Hale Center Theatre…
-
EDWARDS LAUNCHES THE SAPIEN 3 ULTRA RESILIA VALVE IN EUROPE WITH TECHNOLOGY TO ENHANCE DURABILITY
NYON, Switzerland–(BUSINESS WIRE)– Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the…
-
Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business
SALT LAKE CITY, May 07, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
-
Ultradent Announces Acquisition of Ease-In-Shields™ Laser Protection
Ultradent proudly announces the acquisition of Ease-In-Shields™ from ViewMax Solutions, LLC. Ease-In-Shields provides unique eye protection for laser…
-
Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatments
SALT LAKE CITY, UT (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic…
-
ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices
ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.
-
Tether Takes Strategic Stake in Leading Brain-Computer-Interface Company Blackrock Neurotech
Tether Takes Strategic Stake in Leading Brain-Computer-Interface Company Blackrock Neurotech
-
Owlet Announces European Medical Certification of Dream Sock®
Parents will soon have access to Owlet’s Dream Sock with medically-certified CE-Marking across the European markets
-
Thermo Fisher Scientific Launches New CXCL10 Testing Service
Noninvasive urine-based biomarker testing can support routine testing for graft dysfunction
-
Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
The grant designates Altitude Lab as a top acceleration program for biotechnology startups
-
First adult spine surgery using groundbreaking nView s1 imaging and navigation technology announced
First adult spine surgery using groundbreaking nView s1 imaging and navigation technology announced
-
Departing Biochemical Geneticist Leaves Legacy of Scientific Discovery and Devoted Patient Care at ARUP, U of U Health
Nicola Longo, MD, PhD, has spent more than 20 years at University of Utah Health and ARUP Laboratories…
-
SBA Announces 2024 Growth Accelerator Fund Competition Stage One Winners, Up to $3 Million in Prizes Awarded
Competition Opens Doors for Underserved Entrepreneurs in Key Science and Technology Industries
-
Bluewind Announces Release of Efficacy Data
PARK CITY, Utah, April 23, 2024 /PRNewswire/ — BlueWind Medical, Ltd., a pioneer in implantable Tibial NeuroModulation (iTNM)…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
